home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Software Vault: The Diamond Collection
/
The Diamond Collection (Software Vault)(Digital Impact).ISO
/
cdr16
/
med9505a.zip
/
M9550044.TXT
< prev
next >
Wrap
Text File
|
1995-03-04
|
2KB
|
29 lines
Document 0044
DOCN M9550044
TI [Gene therapy and ethics]
DT 9505
AU Muller H; Rehmann-Sutter C; Abteilung Medizinische Genetik,
Universitatskinderklinik, Basel.
SO Schweiz Med Wochenschr. 1995 Jan 10;125(1-2):34-41. Unique Identifier :
AIDSLINE MED/95141036
AB Gene therapy represents a new strategy to treat human disorders. It was
originally conceived as a cure for severe monogenetic disorders. Since
its conception, the spectrum of possible application for gene therapy
has been to include the treatment of acquired diseases, such as various
forms of cancer and some viral infections, most notably human immune
deficiency virus (HIV) and hepatitis B virus. Since somatic gene therapy
does not cause substantially new ethical problems, it has gained broad
approval. This is by no means the case with germ-line gene therapy.
Practically all bodies who were evaluating the related ethical aspects
wanted to ban its medical application on grounds of fundamental and
pragmatic considerations. In this review, practical and ethical views
concerning gene therapy are summarized which were presented at the
Junitagung 1994 of the Swiss Society for Biomedical Ethics in Basle.
DE English Abstract *Ethics, Medical *Gene Therapy Genetic Engineering
Germ-Line Mutation Human Reproduction Techniques JOURNAL ARTICLE
REVIEW REVIEW, TUTORIAL
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).